Strategic News Watch • November 16, 2026 Daily Biopharma Digest – November 16, 2026 November 16, 2026 Summit Therapeutics’ bispecific ivonescimab was turned away by… Pro Hub Membership Required You must be a Pro Hub member to access this content. Join Now Already a member? Log in here